Article Details

Aerie Pharmaceuticals (NASDAQ:AERI) Rating Reiterated by Mizuho

Retrieved on: 2018-01-15 03:18:45

Tags for this article:

Click the tags to see associated articles and topics

Aerie Pharmaceuticals (NASDAQ:AERI) Rating Reiterated by Mizuho. View article details on hiswai:

Excerpt

<div>Alps Advisors Inc invested 0.01% of its portfolio in Aerie Pharmaceuticals, Inc. Sg Americas Securities holds 14,175 shares or 0.01% of its portfolio. (NASDAQ:AERI). Fmr Lc has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). <b>Benchmark Capital</b> Advisors holds 1.11% or 29,400 shares.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up